Pulmonx (LUNG) Return on Sales (2019 - 2025)

Pulmonx (LUNG) has 7 years of Return on Sales data on file, last reported at 0.01% in Q3 2025.

• On a quarterly basis, Return on Sales changed 0.0% year-over-year to 0.01% in Q3 2025; TTM through Sep 2025 was 0.01%, a 0.0% change from a year earlier, with the FY2024 full-year figure at 0.01%, changed 0.0% from the prior year.
• Return on Sales for Q3 2025 stood at 0.01%, down from 0.01% in the prior quarter.
• Over the last five years, Return on Sales for LUNG reached as high as 0.01% in Q4 2024 and fell as low as 0.01% in Q1 2022.
• Historically, Return on Sales has averaged 0.01% across 5 years, with a median of 0.01% in 2023.
• On a YoY basis, Return on Sales climbed as much as 2 bps in 2021 and fell as far as 1 bps in 2021.
• Year by year, Return on Sales stood at 0.01% in 2021, then advanced by 2 bps to 0.01% in 2022, then rose by 22 bps to 0.01% in 2023, then advanced by 23 bps to 0.01% in 2024, then decreased by 17 bps to 0.01% in 2025.
• Per Business Quant data, the three most recent Return on Sales figures were 0.01% in Q3 2025, 0.01% in Q2 2025, and 0.01% in Q1 2025.